New Markers of Disease Progression in Myelofibrosis
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm due to the clonal proliferation of a hematopoietic stem cell. The vast majority of patients harbor a somatic gain of function mutation either of <i>JAK2</i> or <i>MPL</i> or <i>CALR</i> genes in their he...
Guardado en:
Autores principales: | Rita Campanelli, Margherita Massa, Vittorio Rosti, Giovanni Barosi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41225f8fcfb34c65adcfa620ede973bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Disseminated tuberculosis with myelofibrosis presentation: a case report
por: Mahdi Khatuni, et al.
Publicado: (2021) -
Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
por: Omar M. Ismail, et al.
Publicado: (2021) -
VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis
por: Laura Villani, et al.
Publicado: (2021) -
New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
por: Domenico Penna
Publicado: (2021) -
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
por: Magdalena M. Brune, et al.
Publicado: (2021)